CIPO Patents = 2

EPO Patents = 1

Trademarks = 21

Forward Citations = 2

Loading Chart...

5 inventors (with patents filed for the assignee):

Herbert T Nagasawa (4 out of 12 patents)

Jonathan F Cohen (1 out of 2 patents)

Scott Momii (1 out of 1 patent)

4. Scott Nagasawa (1 out of 1 patent)

5. David T Bagley (1 out of 7 patents)

4 patents: Sort by Forward Citations

1. 9173917 - Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug (2015-11-03),

2. 9144570 - Method to enhance delivery of glutathione and ATP levels in cells (2015-09-29),

3. 8853170 - Compositions comprising sugar-cysteine products (2014-10-07),

4. 8501700 - Method to enhance delivery of glutathione and ATP levels in cells (2013-08-06),

Company Overview

Max International, LLC is a leading health and wellness company dedicated to improving people's lives through science-based solutions. With a focus on cellular health, Max offers innovative products that support overall well-being and vitality. The company's mission is to empower individuals to live their best lives by providing high-quality supplements and lifestyle resources.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#287 in Salt Lake City, UT

#778 in Utah

#60,641 in US

Salt Lake City, UT, United States of America

Max International, LLC

Forward Citations = 2

5 inventors:

Herbert T Nagasawa (4 out of 12 patents)

Jonathan F Cohen (1 out of 2 patents)

Scott Momii (1 out of 1 patent)

4. Scott Nagasawa (1 out of 1 patent)

5. David T Bagley (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Max International, LLC. Retrieved from https://idiyas.com/company/max-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]